Viewing StudyNCT00450983



Ignite Creation Date: 2024-05-05 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00450983
Status: TERMINATED
Last Update Posted: 2017-05-24
First Post: 2007-03-20

Brief Title: Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation Thiotepa Fludarabine and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Organization Data

Organization: Fred Hutchinson Cancer Center
Class: OTHER
Study ID: 196500
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Fred Hutchinson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: Ann Woolfrey
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Fred Hutchinson Cancer Center
Old Name: None
Old Organization: None

Collaborators

Name Class
National Institute of Allergy and Infectious Diseases NIAID NIH
National Cancer Institute NCI NIH